Osteoporosis Drug Treatment Update

The Brazilian population is aging and the prevalence of chronic degenerative diseases, including osteoporosis, is increasing. The diagnosis and treatment of osteoporosis have made significant advances in the last decade. The orthopedist and traumatologist can no longer be detained only in the surgic...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliveira, Lindomar Guimarães, Carneiro, Mara Lúcia Rassi Guimarães, Souza, Márcio Passini Gonçalves de, Souza, Caio Gonçalves de, Moraes, Frederico Barra de, Camargo, Fábio Lopes de
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Revinter Publicações Ltda. 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558937/
https://www.ncbi.nlm.nih.gov/pubmed/34733425
http://dx.doi.org/10.1055/s-0040-1714219
_version_ 1784592668692578304
author Oliveira, Lindomar Guimarães
Carneiro, Mara Lúcia Rassi Guimarães
Souza, Márcio Passini Gonçalves de
Souza, Caio Gonçalves de
Moraes, Frederico Barra de
Camargo, Fábio Lopes de
author_facet Oliveira, Lindomar Guimarães
Carneiro, Mara Lúcia Rassi Guimarães
Souza, Márcio Passini Gonçalves de
Souza, Caio Gonçalves de
Moraes, Frederico Barra de
Camargo, Fábio Lopes de
author_sort Oliveira, Lindomar Guimarães
collection PubMed
description The Brazilian population is aging and the prevalence of chronic degenerative diseases, including osteoporosis, is increasing. The diagnosis and treatment of osteoporosis have made significant advances in the last decade. The orthopedist and traumatologist can no longer be detained only in the surgical treatment of osteoporotic fracture. It is extremely important that we know: 1) what risk factors to evaluate, and the Fracture Risk Assesment Tool (FRAX) can be used; 2) which complementary tests should be requested, such as densitometry, radiography of the spine and pelvis, blood and urine tests, and even bone biopsy; 3) which supplements to use, such as calcium and magnesium, vitamins D and K; 4) which medications to prescribe, antiresorptives or trainers, therapeutic windows and adverse events.
format Online
Article
Text
id pubmed-8558937
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Thieme Revinter Publicações Ltda.
record_format MEDLINE/PubMed
spelling pubmed-85589372021-11-02 Osteoporosis Drug Treatment Update Oliveira, Lindomar Guimarães Carneiro, Mara Lúcia Rassi Guimarães Souza, Márcio Passini Gonçalves de Souza, Caio Gonçalves de Moraes, Frederico Barra de Camargo, Fábio Lopes de Rev Bras Ortop (Sao Paulo) The Brazilian population is aging and the prevalence of chronic degenerative diseases, including osteoporosis, is increasing. The diagnosis and treatment of osteoporosis have made significant advances in the last decade. The orthopedist and traumatologist can no longer be detained only in the surgical treatment of osteoporotic fracture. It is extremely important that we know: 1) what risk factors to evaluate, and the Fracture Risk Assesment Tool (FRAX) can be used; 2) which complementary tests should be requested, such as densitometry, radiography of the spine and pelvis, blood and urine tests, and even bone biopsy; 3) which supplements to use, such as calcium and magnesium, vitamins D and K; 4) which medications to prescribe, antiresorptives or trainers, therapeutic windows and adverse events. Thieme Revinter Publicações Ltda. 2021-10-28 /pmc/articles/PMC8558937/ /pubmed/34733425 http://dx.doi.org/10.1055/s-0040-1714219 Text en Sociedade Brasileira de Ortopedia e Traumatologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Oliveira, Lindomar Guimarães
Carneiro, Mara Lúcia Rassi Guimarães
Souza, Márcio Passini Gonçalves de
Souza, Caio Gonçalves de
Moraes, Frederico Barra de
Camargo, Fábio Lopes de
Osteoporosis Drug Treatment Update
title Osteoporosis Drug Treatment Update
title_full Osteoporosis Drug Treatment Update
title_fullStr Osteoporosis Drug Treatment Update
title_full_unstemmed Osteoporosis Drug Treatment Update
title_short Osteoporosis Drug Treatment Update
title_sort osteoporosis drug treatment update
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558937/
https://www.ncbi.nlm.nih.gov/pubmed/34733425
http://dx.doi.org/10.1055/s-0040-1714219
work_keys_str_mv AT oliveiralindomarguimaraes osteoporosisdrugtreatmentupdate
AT carneiromaraluciarassiguimaraes osteoporosisdrugtreatmentupdate
AT souzamarciopassinigoncalvesde osteoporosisdrugtreatmentupdate
AT souzacaiogoncalvesde osteoporosisdrugtreatmentupdate
AT moraesfredericobarrade osteoporosisdrugtreatmentupdate
AT camargofabiolopesde osteoporosisdrugtreatmentupdate

Ejemplares similares